Protective effects of sleep duration and physical activity on cognitive performance are influenced by β-amyloid and brain volume but not tau burden among cognitively unimpaired older adults

Protective effects of sleep duration and physical activity on cognitive performance are influenced by β-amyloid and brain volume but not tau burden among cognitively unimpaired older adults

Background and objectives: Sleep and physical activity have gained traction as modifiable risk factors for Alzheimer’s disease. Sleep duration is linked to amyloid-β clearance while physical activity is associated with brain volume maintenance. We investigate how sleep duration and physical activity...

Full description

Bibliographic Details
Main Authors:	Vahan Aslanyan, Nancy Ortega, Laura Fenton, Theresa M. Harrison, Rema Raman, Wendy J. Mack, Judy Pa
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	NeuroImage: Clinical
Subjects:	Alzheimer's Disease Physical activity Sleep Cognition Structural MRI PET
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158223001493

Similar Items

Cerebral blood flow, tau imaging, and memory associations in cognitively unimpaired older adults
by: Alexandra J. Weigand, et al.
Published: (2022-01-01)

Optimizing quantification of MK6240 tau PET in unimpaired older adults
by: Theresa M. Harrison, et al.
Published: (2023-01-01)

APOE -ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
by: Anna Brugulat-Serrat, et al.
Published: (2023-03-01)

APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly
by: Anniina Snellman, et al.
Published: (2023-04-01)

The Association of Plasma Amyloid-β and Cognitive Decline in Cognitively Unimpaired Population
by: Wang J, et al.
Published: (2022-04-01)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
by: Anna Rubinski, et al.
Published: (2020-10-01)

The A4 study: β‐amyloid and cognition in 4432 cognitively unimpaired adults
by: Philip S. Insel, et al.
Published: (2020-05-01)

Amyloid beta associations with connected speech in cognitively unimpaired adults
by: Kimberly D. Mueller, et al.
Published: (2021-01-01)

Reasons for undergoing amyloid imaging among cognitively unimpaired older adults
by: Mary M. Ryan, et al.
Published: (2021-08-01)

Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.
by: Emily A Largent, et al.
Published: (2020-01-01)

Mesial temporal tau in amyloid-β-negative cognitively normal older persons
by: Natasha Krishnadas, et al.
Published: (2022-04-01)

Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals
by: Lyduine E. Collij, et al.
Published: (2021-01-01)

Tau pathology in cognitively normal older adults
by: Jacob Ziontz, et al.
Published: (2019-12-01)

Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
by: Davina Biel, et al.
Published: (2021-08-01)

Classification and prediction of cognitive trajectories of cognitively unimpaired individuals
by: Young Ju Kim, et al.
Published: (2023-03-01)

Selective Serotonin Reuptake Inhibitor-Treatment Does Not Show Beneficial Effects on Cognition or Amyloid Burden in Cognitively Impaired and Cognitively Normal Subjects
by: Yvonne Bouter, et al.
Published: (2022-06-01)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
by: Shannon L. Risacher, et al.
Published: (2019-12-01)

Effects of Cognitive Reserve in Alzheimer’s Disease and Cognitively Unimpaired Individuals
by: Dong Hyuk Lee, et al.
Published: (2022-02-01)

Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer’s Disease with APP Osaka Mutation
by: Hiroyuki Shimada, et al.
Published: (2020-06-01)

Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment
by: Nidhi S. Mundada, et al.
Published: (2023-09-01)

Sleep Time Estimated by an Actigraphy Watch Correlates With CSF Tau in Cognitively Unimpaired Elders: The Modulatory Role of APOE
by: Sara López-García, et al.
Published: (2021-08-01)

GABA and glutamate moderate beta-amyloid related functional connectivity in cognitively unimpaired old-aged adults
by: F.C. Quevenco, et al.
Published: (2019-01-01)

Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
by: Hugh G. Pemberton, et al.
Published: (2023-05-01)

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease
by: Daniel J. Norton, et al.
Published: (2020-08-01)

Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals
by: Sung Hoon Kang, et al.
Published: (2023-10-01)

Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI
by: Paula M. Petrone, et al.
Published: (2019-08-01)

Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study
by: Fatemah A. Sakr, et al.
Published: (2019-01-01)

Relationship between baseline plasma p‐tau181 and longitudinal changes in cognition and structural brain measures in a cohort of cognitively unimpaired older adults
by: Marcos V. Pais, et al.
Published: (2023-10-01)

Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia
by: Dawn C. Matthews, et al.
Published: (2021-01-01)

Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer’s disease
by: Yue Cai, et al.
Published: (2023-02-01)

Generalizability of cognitive results from clinical trial participants to an older adult population: Addressing external validity
by: Vahan Aslanyan, et al.
Published: (2023-04-01)

Correlations between APOE4 allele and regional amyloid and tau burdens in cognitively normal older individuals
by: Yun Jeong Hong, et al.
Published: (2022-08-01)

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
by: DL Tudorascu, et al.
Published: (2020-01-01)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
by: Fangyang Jiao, et al.
Published: (2023-02-01)

Tau PET burden in Brodmann areas 35 and 36 is associated with individual differences in cognition in non-demented older adults
by: Nisha Rani, et al.
Published: (2023-12-01)

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
by: Tracy R. Melzer, et al.
Published: (2019-04-01)

Molecular Imaging of Fluorinated Probes for Tau Protein and Amyloid-β Detection
by: Sarah K. Yeo, et al.
Published: (2020-07-01)

Cognitive trajectories of patients with focal ß-amyloid deposition
by: Si Eun Kim, et al.
Published: (2021-02-01)

Respective influence of beta-amyloid and APOE ε4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults
by: Robin de Flores, et al.
Published: (2023-06-01)

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
by: Edmond Teng, et al.
Published: (2021-12-01)